NAM; Sangkil
Patent Applications and Registrations
Patent applications and USPTO patent grants for NAM; Sangkil.The latest application filed is for "5-bromo-indirubins".
- NAM; Sangkil - Tujunga CA
- Nam; Sangkil - Tujunaga CA
- NAM; Sangkil - Duarte CA
- Nam; Sangkil - Tijunga CA
- Nam; Sangkil - Monrovia CA
- Nam; Sangkil - South Pasadena CA
- Nam; Sangkil - Tampa FL
| Patent | Date |
|---|---|
| 5-bromo-indirubins App 20220274964 - JOVE; Richard ; et al. | 2022-09-01 |
| 5-bromo-indirubins Grant 11,306,072 - Jove , et al. April 19, 2 | 2022-04-19 |
| Thioindirubins Grant 11,213,510 - Nam , et al. January 4, 2 | 2022-01-04 |
| Pyridopyrazine compounds and uses thereof Grant 11,117,894 - Nam , et al. September 14, 2 | 2021-09-14 |
| T-cell Lymphoma Treatments App 20210145840 - Horne; David ; et al. | 2021-05-20 |
| Pyridopyrazine Compounds And Uses Thereof App 20210139476 - Nam; Sangkil ; et al. | 2021-05-13 |
| Dithio Etp Derivatives App 20210115066 - Nam; Sangkil ; et al. | 2021-04-22 |
| 5-bromo-indirubins App 20210053919 - Nam; Sangkil ; et al. | 2021-02-25 |
| Thioindirubins App 20200345693 - Nam; Sangkil ; et al. | 2020-11-05 |
| Dithio ETP derivatives Grant 10,822,353 - Nam , et al. November 3, 2 | 2020-11-03 |
| 5-bromo-indirubins App 20200283421 - Jove; Richard ; et al. | 2020-09-10 |
| Indirubin Derivatives, And Uses Thereof App 20200247750 - Kind Code | 2020-08-06 |
| 5-bromo-indirubins Grant 10,703,718 - Nam , et al. | 2020-07-07 |
| Indirubin derivatives, and uses thereof Grant 10,435,367 - Nam , et al. O | 2019-10-08 |
| Dithio Etp Derivatives App 20190211034 - Nam; Sangkil ; et al. | 2019-07-11 |
| ETP derivatives Grant 10,246,471 - Overman , et al. | 2019-04-02 |
| 5-bromo-indirubins App 20180170915 - Jove; Richard ; et al. | 2018-06-21 |
| 5-bromo-indirubins App 20180170870 - Nam; Sangkil ; et al. | 2018-06-21 |
| Etp Derivatives App 20180155367 - Overman; Larry Eugene ; et al. | 2018-06-07 |
| ETP derivatives Grant 9,856,273 - Overman , et al. January 2, 2 | 2018-01-02 |
| Isatin derivatives, pharmaceutical compositions thereof, and methods of use thereof Grant 9,828,342 - Horne , et al. November 28, 2 | 2017-11-28 |
| Etp Derivatives App 20170037058 - Overman; Larry Eugene ; et al. | 2017-02-09 |
| ETP derivatives Grant 9,527,868 - Overman , et al. December 27, 2 | 2016-12-27 |
| Indirubin derivatives and uses thereof in treating chronic myelogenous leukemia Grant 9,512,076 - Jove , et al. December 6, 2 | 2016-12-06 |
| 5-bromo-indirubins App 20160068517 - Jove; Richard ; et al. | 2016-03-10 |
| Berbamine derivatives Grant 9,233,976 - Horne , et al. January 12, 2 | 2016-01-12 |
| Etp Derivatives App 20150291622 - Overman; Larry Eugene ; et al. | 2015-10-15 |
| 5-bromo-indirubins App 20150259288 - Nam; Sangkil ; et al. | 2015-09-17 |
| Indirubin Derivatives, And Uses Thereof App 20140275168 - NAM; Sangkil ; et al. | 2014-09-18 |
| Berbamine Derivatives App 20140155423 - HORNE; David ; et al. | 2014-06-05 |
| Berbamine derivatives Grant 8,722,698 - Horne , et al. May 13, 2 | 2014-05-13 |
| Isatin Derivatives, Pharmaceutical Compositions Thereof, And Methods Of Use Thereof App 20130225637 - Horne; David A. ; et al. | 2013-08-29 |
| Indirubin Derivatives And Uses Thereof In Treating Chronic Myelogenous Leukemia App 20130210834 - Jove; Richard ; et al. | 2013-08-15 |
| Synthesis of grossularines-1 and analogs thereof and method of use Grant 7,615,638 - Horne , et al. November 10, 2 | 2009-11-10 |
| Synthesis Of Grossularines-1 And Analogs Thereof And Method Of Use App 20080033004 - Horne; David A. ; et al. | 2008-02-07 |
| Tea polyphenol esters and analogs thereof for cancer prevention and treatment Grant 6,713,506 - Dou , et al. March 30, 2 | 2004-03-30 |
| Tea polyphenol esters and analogs thereof for cancer prevention and treatment App 20020151582 - Dou, Q. Ping ; et al. | 2002-10-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 